SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEbiquity Regulatory News (EBQ)

Share Price Information for Ebiquity (EBQ)

Share Price is delayed by 15 minutes
Get Live Data
10.75    0.00 (0.00%)
Bid:
10.50
Ask:
11.00
Spread: 0.50 (4.762%)
Market Cap: £14.94m
EBQ Live PriceLast checked at - London Stock Exchange

Intraday Ebiquity Share Chart

Director/PDMR Shareholding

13 May 2010 07:00

RNS Number : 8268L
Ebiquity PLC
13 May 2010
 



Ebiquity Plc

("Ebiquity" or "the Company")

 

Directors' Dealings

 

As was set out in the circular that was sent to shareholders recently in relation to the acquisitions of Xtreme Information Services Limited and Thomson Media Control GmbH & Co KG, the Company has now implemented an amended and enhanced incentive arrangement for key executives, in particular Michael Greenlees and Nick Manning.

 

As a result, a total of 4.2 million ordinary shares have today been issued to the Company's employee benefit trust ("EBT"). 2.4 million of these ordinary shares are for the benefit of Michael Greenlees and 1.8 million are for the benefit of Nick Manning. Of these, 600,000 and 450,000 respectively will vest immediately and may be acquired at 35 pence per share but even if the rights to acquire them are exercised, they must be retained until after the announcement of the Company's results for the financial year ended 30 April 2011.

 

Vesting of the balance (which will also have an acquisition cost of 35 pence per share) will be subject to the satisfaction of new performance criteria designed to achieve growth of the business while at the same time maintaining and enhancing the underlying earnings per share over a period of three years ending on 30 April 2013. The two measures will be earnings per share and revenue targets with the minimum EPS target having to be satisfied before any of the shares comprised in either part of the award can vest. All vested shares must be retained for a minimum of 12 months after vesting before they can be sold.

 

The Remuneration Committee in conjunction with the Audit Committee will be responsible for

determining whether and to what extent these targets have been satisfied.

 

As a result of these arrangements, the Directors will have the following interest in the ordinary shares of the Company:

 

Michael Greenless

Current Holding: 230,000

Holding following full vesting of the ordinary shares in the EBT to which Michael Greenlees has an interest: 2,630,000

 

Nick Manning

Current Holding: 230,000

Holding following full vesting of the ordinary shares in the EBT to which Nick Manning has an interest: 2,030,000

 

The Company has today applied for the 4.2m shares to be admitted to AIM and admission is expected on Tuesday 18 May 2010.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSGGURGAUPUGBP
Date   Source Headline
28th May 20265:04 pmRNSResult of AGM
1st May 20261:15 pmRNSNotice of ARA and AGM
27th Apr 202611:42 amRNSNotification of Major Holdings
21st Apr 20262:35 pmRNSHolding(s) in Company
21st Apr 20267:00 amRNSFinal Results
13th Apr 20261:31 pmRNSNotice of Investor Presentation
13th Apr 20261:29 pmRNSNotice of Results
31st Mar 20267:00 amRNSTotal Voting Rights
20th Mar 20264:17 pmRNSTotal Voting Rights
9th Mar 202612:36 pmRNS-REbiquity Appoints Head of Growth, Americas
6th Feb 202610:03 amRNS-REbiquity Strategic Leadership Appointment
22nd Jan 20267:00 amRNSTrading Update
24th Nov 202512:33 pmRNSTR-1: Notification of Major Holdings
21st Oct 20258:00 amRNS-REbiquity Joins Ad Context Protocol
15th Oct 20259:27 amRNSNotification of Major Holdings
3rd Oct 20257:00 amRNSDirector/PDMR Shareholding
1st Oct 20251:22 pmRNS-RInvestor Presentation
1st Oct 20251:17 pmRNSDirector/PDMR Shareholding
29th Sep 20257:00 amRNSInterim Results
23rd Sep 20257:00 amRNSTrading Update
16th Sep 20257:00 amRNS-RNotice of Investor Presentation
2nd Sep 20257:00 amRNS-RLaunch of Advisory Board to Drive Strategic Growth
1st Sep 20257:00 amRNSBoard Changes
21st Aug 202511:53 amRNSNotification of Major Holdings
6th Aug 20258:30 amRNSTrading Update and Notice of Interim Results
29th Jul 202511:32 amRNSAllotment of Shares and Total Voting Rights
29th Jul 20259:22 amRNSBoard Appointments
24th Jun 20254:03 pmRNS-REbiquity Strengthens Americas Leadership
10th Jun 20257:00 amRNS-RAwarded Silver as a Top UK Media Consultancy
4th Jun 20255:24 pmRNSResult of AGM
22nd May 20257:00 amRNSDirector/PDMR Shareholding
2nd May 202511:59 amRNSAnnual Report and Notice of Annual General Meeting
22nd Apr 20257:00 amRNSFinal Results
10th Apr 20252:41 pmRNSNotice of Results
9th Apr 20257:00 amRNSNotification of major holdings
31st Mar 20254:33 pmRNSTotal Voting Rights
19th Mar 202510:00 amRNSHolding(s) in Company
19th Mar 202510:00 amRNSHolding(s) in Company
12th Mar 202510:46 amRNSIssue of Shares and TVR
3rd Mar 20257:00 amRNSAppointment of Chief Financial Officer
17th Feb 20257:00 amRNSAppointment of NOMAD and Trading Update
5th Dec 20247:00 amRNSTrading Update
19th Nov 20247:00 amRNSDirectorate Change
3rd Oct 20244:22 pmRNSTotal Voting Rights
30th Sep 20249:27 amRNSNotification of major holdings
26th Sep 20247:00 amRNSInterim Results
23rd Sep 20241:56 pmRNSNotification of major holdings
22nd Aug 202410:55 amRNSTrading Update and Notice of results
22nd Aug 20247:00 amRNSTrading Update and Notice of results
5th Aug 20247:00 amRNSDirectorate change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.